Potential Target Metabolites From Gut Microbiota Against Hepatocellular Carcinoma: A Network Pharmacology and Molecular Docking Study
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide, posing significant challenges and economic burdens on healthcare systems. Gut microbiota metabolites have shown promise in cancer treatment, but the specific active metabolites and their key targets remain unclear....
Saved in:
| Main Authors: | Sehar Aslam, Muhammad Qasim, Fatima Noor, Muhammad Shahid, Usman Ali Ashfaq, Samman Munir, Helal F. Al-Harthi, Mutaib M. Mashraqi, Umair Waqas, Mohsin Khurshid |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | International Journal of Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2024/4286228 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integrative Network Pharmacology to Evaluate Bioactive Phytochemicals of Aesculus hippocastanum and Their Multitarget Mechanisms Against Chronic Venous Insufficiency
by: Zeeshan Shokat, et al.
Published: (2025-01-01) -
Identification of metabolites from the gut microbiota in hypertension via network pharmacology and molecular docking
by: Wenjie Zhang, et al.
Published: (2024-10-01) -
Exploring the health benefits of gut microbiota metabolites on combating ulcerative colitis via network pharmacology, bioinformatics and molecular docking
by: Weiguo Yao, et al.
Published: (2025-07-01) -
The integration of metabolites from Forsythia suspensa and gut microbiota ameliorates drug-induced liver injury: network pharmacology and molecular docking studies
by: Yanni Wang, et al.
Published: (2025-12-01) -
Unveiling the mechanisms of Tianjihuang in hepatocellular carcinoma: a network pharmacology and molecular docking study
by: Bixing Liang, et al.
Published: (2025-06-01)